Anticoagulation in High Bleeding Risk Cancer Patients - Dr Nolukholo Ncete

Anticoagulation in High Bleeding Risk Cancer Patients - Dr Nolukholo Ncete

The Royal College of Pathologists via YouTube Direct link

Intro

1 of 25

1 of 25

Intro

Class Central Classrooms beta

YouTube videos curated by Class Central.

Classroom Contents

Anticoagulation in High Bleeding Risk Cancer Patients - Dr Nolukholo Ncete

Automatically move to the next video in the Classroom when playback concludes

  1. 1 Intro
  2. 2 Introduction continued...
  3. 3 Incidental VTE's
  4. 4 Cancer-associated risk factors for VTE
  5. 5 What the management may look like?
  6. 6 LMWH versus VKA
  7. 7 LMWH versus DOACs
  8. 8 Edoxaban
  9. 9 Apixaban
  10. 10 Considerations prior to prescribing DOACs in CAT
  11. 11 Thrombocytopenia continued...
  12. 12 Renal impairment & LMWH
  13. 13 Dosing recommendations according to creatinine clearance in mL/min
  14. 14 GIT/GU malignancy
  15. 15 Hepatic impairment continued...
  16. 16 Use of antiplatelet agents
  17. 17 Low body weight
  18. 18 Abnormal uterine bleeding
  19. 19 Intracranial lesions
  20. 20 The role of IVC filters
  21. 21 Mechanical prophylaxis
  22. 22 When to measure DOACs?
  23. 23 DOAC testing continued...
  24. 24 Monitoring of patients on LMWH
  25. 25 Warfarin initiation

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.